Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Florian Grebien(Austrian Academy of Sciences), Masoud Vedadi(University of Toronto), Matthäus Getlik(Ontario Institute for Cancer Research), Roberto Giambruno(Austrian Academy of Sciences), Amit Grover(MRC Weatherall Institute of Molecular Medicine), Roberto Avellino(Erasmus MC), Anna Skucha(Austrian Academy of Sciences), Sarah Vittori(Austrian Academy of Sciences), Ekaterina Kuznetsova(University of Toronto), David Smil(University of Toronto), Dalia Baršytė-Lovejoy(University of Toronto), Fengling Li(University of Toronto), Gennadiy Poda(Ontario Institute for Cancer Research), Matthieu Schapira(University of Toronto), Hong Wu(University of Toronto), Aiping Dong(University of Toronto), Guillermo Senisterra(University of Toronto), Alexey Stukalov(Austrian Academy of Sciences), K. Huber(Austrian Academy of Sciences), Andreas Schönegger(Austrian Academy of Sciences), Richard Marcellus(Ontario Institute for Cancer Research), Martin Bilban(Vienna Biocenter), Christoph Bock(Austrian Academy of Sciences), Peter J. Brown(University of Toronto), Johannes Zuber(Research Institute of Molecular Pathology), Keiryn L. Bennett(Austrian Academy of Sciences), Rima Al‐awar(Ontario Institute for Cancer Research), Ruud Delwel(Erasmus MC), Claus Nerlov(MRC Weatherall Institute of Molecular Medicine), C.H. Arrowsmith(University of Toronto), Giulio Superti‐Furga(Austrian Academy of Sciences)
Nature Chemical Biology
July 13, 2015
Cited by 291Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis